Summary
Cystic fibrosis (CF) lung disease, driven by ion transport defects and mucus issues, remains a primary cause of death. This review covers CF diagnosis, lung disease pathogenesis, and current/novel treatments, including lung transplantation.
Area of Science:
- Pulmonary Medicine
- Genetics
- Cell Biology
Background:
- Lung disease is the leading cause of death in cystic fibrosis (CF) patients, despite improved treatments.
- Airway epithelial ion and water transport defects lead to dehydrated mucus, impairing clearance and causing airway obstruction.
- Mucus plugging, infection, and inflammation drive progressive lung damage, including bronchiectasis.
Purpose of the Study:
- To review the lung involvement in cystic fibrosis.
- To summarize advancements in CF diagnosis and lung disease pathogenesis.
- To discuss current and novel therapeutic strategies, including lung transplantation.
Main Methods:
- Literature review focusing on cystic fibrosis lung disease.
- Synthesis of current understanding of CF pathogenesis.
- Overview of diagnostic approaches and therapeutic modalities.
Main Results:
- CF lung disease is characterized by progressive airway obstruction, infection, and inflammation.
- Defective ion transport and increased mucin secretion contribute to mucus dehydration and impaired clearance.
- Despite advances, lung disease progression and respiratory failure remain significant challenges.
Conclusions:
- Understanding CF pathogenesis is crucial for developing effective treatments.
- Novel therapies targeting the underlying genetic defect offer future promise.
- Lung transplantation remains a vital option for end-stage CF lung disease.
Keywords:
Pseudomonas aeruginosaairway surface liquidbronchiectasiscystic fibrosiscystic fibrosis transmembrane regulatorendobronchial infection and inflammationmucociliary clearanceMore Related Videos
Related Concept Videos
01:23Cystic Fibrosis: Pathogenesis
670
Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
670
01:24Cystic Fibrosis: Management
416
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
416
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.1K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.5K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.5K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K
01:20COPD: Pathogenesis and Clinical Features
1.7K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.7K